NEXT MEETING: HOUSTON, TEXAS - AUGUST 3-7 2026

Endocrine disrupting compounds (EDCs) impose an estimated $340 billion annual economic burden on the United States, representing costs comparable to major chronic diseases and conditions, yet much of this burden is considered preventable. Unlike traditional contaminants, EDCs disrupt biological signaling at parts-per-trillion concentrations, producing effects that may not manifest for years or generations after exposure. This presentation traces endocrine disruption science through critical case studies including diethylstilbestrol (DES), triclosan, BPA, and PCBs, revealing a consistent pattern: environmental persistence translates to pervasive biological impacts - with lipophilic compounds bioaccumulating and biomagnifying to concentrations far exceeding environmental levels.

Health implications span reproduction, neurodevelopment, metabolism, and transgenerational effects, with developmental timing often mattering more than dose. Managing EDCs requires coordinated action across individual choices, industrial innovation, and regulatory reform, but none will succeed without robust environmental monitoring. Advanced analytical techniques enable early contaminant detection before population-level impacts appear, identify hotspots, validate efficacy of preventative management, and inform evidence-based policy.

We cannot manage what we cannot measure. Robust environmental monitoring programs deliver the data needed to protect vulnerable populations, deploy effective treatment technologies, and prevent future exposures rather than resorting to responding to past harm.